Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Collett, Marc SHincks, Jeffrey R
Benschop, Kimberley
Duizer, Erwin
van der Avoort, Harrie
Rhoden, Eric
Liu, Hongmei
Oberste, M Steven
McKinlay, Mark A
Hartford, Marianne
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model.Published in
J Infect Dis 2017; 215(3):335-43Publiekssamenvatting
Immunodeficient individuals who excrete vaccine-derived polioviruses threaten polio eradication. Antivirals address this threat.PMID
27932608ae974a485f413a2113503eed53cd6c53
10.1093/infdis/jiw542
Scopus Count
Collections
Related articles
- Clearance of Immunodeficiency-associated Vaccine-derived Poliovirus Infection With Pocapavir.
- Authors: Copelyn J, Hincks JR, Wilmshurst JM, Petersen W, Howard W, Jallow S, Moonsamy S, Seakamela L, Suchard M, Collett MS, Eley B
- Issue date: 2020 May
- Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden.
- Authors: Brickley EB, Connor RI, Wieland-Alter WF, Collett MS, Hartford M, Van Der Avoort H, Boesch AW, Weiner JA, Ackerman ME, McKinlay MA, Arita M, Bandyopadhyay AS, Modlin JF, Wright PF
- Issue date: 2019
- Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.
- Authors: McKinlay MA, Collett MS, Hincks JR, Oberste MS, Pallansch MA, Okayasu H, Sutter RW, Modlin JF, Dowdle WR
- Issue date: 2014 Nov 1
- Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
- Authors: O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, Rüttimann R, Costa Clemens SA, Chilean IPV/bOPV study group.
- Issue date: 2015 Nov
- Monovalent type 1 oral poliovirus vaccine in newborns.
- Authors: el-Sayed N, el-Gamal Y, Abbassy AA, Seoud I, Salama M, Kandeel A, Hossny E, Shawky A, Hussein HA, Pallansch MA, van der Avoort HG, Burton AH, Sreevatsava M, Malankar P, Wahdan MH, Sutter RW
- Issue date: 2008 Oct 16